Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells.
about
Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in miceIdentification of functional modules that correlate with phenotypic difference: the influence of network topology.Dormant tumor-suppressor pathways in tumors.Medullary thyroid carcinoma: targeted therapies and future directionsGrowth arrest signaling of the Raf/MEK/ERK pathway in cancer.Signaling mechanisms in neuroendocrine tumors as targets for therapy.The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cellsSynergistic effect of pasireotide and teriflunomide in carcinoids in vitro.IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line.Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation.Molecular challenges of neuroendocrine tumors.
P2860
Q26748741-FA973678-A647-40BA-8021-CE9186578700Q28344105-FA42FCCC-2C00-4D12-A010-F25BFB738E85Q30494575-D2893933-884F-42C5-B034-CD095CF7D199Q33547606-DFE32B26-C220-45DC-B7BD-678801050222Q33557376-5DE5646D-CEDE-4662-AA71-5B87932824FDQ33836237-7AD85D2D-B983-433F-BE83-4ECDF137F976Q34447484-41D78587-EF0B-497D-A513-82C671E5637FQ34811541-258E09A7-F322-4925-A869-DDE9ADFA85A8Q34992484-5B468800-F429-43DC-AAA5-9310EFC67CD3Q36536629-70874C34-FE31-42AD-B7EC-C5C551BAA1BBQ38333692-85003F16-965D-4A58-8F66-7A036E6E7711Q39791081-0D245266-36F0-4E8C-B400-689A0469AB43Q40008963-7E848BAB-6AFF-46D1-B879-2E1895EAB93CQ44506841-FEDB9C90-BE4D-4FA2-83FC-C8E83252E8F2Q46131414-4C79FE4D-EABA-4959-A362-530113568AF5Q49875027-70162A0E-D3DF-4454-95B0-955105517657
P2860
Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Raf-1 causes growth suppressio ...... small-cell lung cancer cells.
@en
type
label
Raf-1 causes growth suppressio ...... small-cell lung cancer cells.
@en
prefLabel
Raf-1 causes growth suppressio ...... small-cell lung cancer cells.
@en
P2093
P2860
P356
P1476
Raf-1 causes growth suppressio ...... small-cell lung cancer cells.
@en
P2093
P2860
P304
P356
10.1165/AJRCMB.20.4.3406
P577
1999-04-01T00:00:00Z